Work

Risk Stratified Treatment for Patients with Newly Diagnosed Juvenile Myelomonocytic Leukemia: A Phase 1/2 Non-Randomized Study of Trametinib and Azacitidine with or without Chemotherapy

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-177838

Authors: Elliot Stieglitz, Yueh-Yun Chi, Bill H. Chang, Sarah K. Tasian, Marielle Yohe, Christopher C Dvorak, Erica Southworth, Janel R. Long-Boyle, Jessica Van Ziffle, Zied Abdullaev, Roy Leong, Alan S. Wayne, Deepa Bhojwani, Mignon L. Loh

Institutions: University of California, San Francisco, Children's Hospital of Los Angeles, Oregon Health & Science University, Children's Hospital of Philadelphia, National Institutes of Health, Seattle Children's Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389234580

Cites:

Cited by: 3

Related to: 10